1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adalimumab Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Adalimumab Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Adalimumab Injection by Country/Region, 2018, 2022 & 2029
2.2 Adalimumab Injection Segment by Type
2.2.1 40mg/0.8ml
2.2.2 20mg/0.4ml
2.3 Adalimumab Injection Sales by Type
2.3.1 Global Adalimumab Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Adalimumab Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Adalimumab Injection Sale Price by Type (2018-2023)
2.4 Adalimumab Injection Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Adalimumab Injection Sales by Application
2.5.1 Global Adalimumab Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Adalimumab Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Adalimumab Injection Sale Price by Application (2018-2023)
3 Global Adalimumab Injection by Company
3.1 Global Adalimumab Injection Breakdown Data by Company
3.1.1 Global Adalimumab Injection Annual Sales by Company (2018-2023)
3.1.2 Global Adalimumab Injection Sales Market Share by Company (2018-2023)
3.2 Global Adalimumab Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Adalimumab Injection Revenue by Company (2018-2023)
3.2.2 Global Adalimumab Injection Revenue Market Share by Company (2018-2023)
3.3 Global Adalimumab Injection Sale Price by Company
3.4 Key Manufacturers Adalimumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Adalimumab Injection Product Location Distribution
3.4.2 Players Adalimumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Adalimumab Injection by Geographic Region
4.1 World Historic Adalimumab Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Adalimumab Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Adalimumab Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Adalimumab Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Adalimumab Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Adalimumab Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Adalimumab Injection Sales Growth
4.4 APAC Adalimumab Injection Sales Growth
4.5 Europe Adalimumab Injection Sales Growth
4.6 Middle East & Africa Adalimumab Injection Sales Growth
5 Americas
5.1 Americas Adalimumab Injection Sales by Country
5.1.1 Americas Adalimumab Injection Sales by Country (2018-2023)
5.1.2 Americas Adalimumab Injection Revenue by Country (2018-2023)
5.2 Americas Adalimumab Injection Sales by Type
5.3 Americas Adalimumab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adalimumab Injection Sales by Region
6.1.1 APAC Adalimumab Injection Sales by Region (2018-2023)
6.1.2 APAC Adalimumab Injection Revenue by Region (2018-2023)
6.2 APAC Adalimumab Injection Sales by Type
6.3 APAC Adalimumab Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Adalimumab Injection by Country
7.1.1 Europe Adalimumab Injection Sales by Country (2018-2023)
7.1.2 Europe Adalimumab Injection Revenue by Country (2018-2023)
7.2 Europe Adalimumab Injection Sales by Type
7.3 Europe Adalimumab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Adalimumab Injection by Country
8.1.1 Middle East & Africa Adalimumab Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Adalimumab Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Adalimumab Injection Sales by Type
8.3 Middle East & Africa Adalimumab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Adalimumab Injection
10.3 Manufacturing Process Analysis of Adalimumab Injection
10.4 Industry Chain Structure of Adalimumab Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Adalimumab Injection Distributors
11.3 Adalimumab Injection Customer
12 World Forecast Review for Adalimumab Injection by Geographic Region
12.1 Global Adalimumab Injection Market Size Forecast by Region
12.1.1 Global Adalimumab Injection Forecast by Region (2024-2029)
12.1.2 Global Adalimumab Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Adalimumab Injection Forecast by Type
12.7 Global Adalimumab Injection Forecast by Application
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Adalimumab Injection Product Portfolios and Specifications
13.1.3 AbbVie Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Adalimumab Injection Product Portfolios and Specifications
13.2.3 Amgen Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Adalimumab Injection Product Portfolios and Specifications
13.3.3 Sandoz Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Adalimumab Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Biogen
13.5.1 Biogen Company Information
13.5.2 Biogen Adalimumab Injection Product Portfolios and Specifications
13.5.3 Biogen Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biogen Main Business Overview
13.5.5 Biogen Latest Developments
13.6 Celltrion
13.6.1 Celltrion Company Information
13.6.2 Celltrion Adalimumab Injection Product Portfolios and Specifications
13.6.3 Celltrion Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Celltrion Main Business Overview
13.6.5 Celltrion Latest Developments
13.7 Cadila Pharmaceuticals
13.7.1 Cadila Pharmaceuticals Company Information
13.7.2 Cadila Pharmaceuticals Adalimumab Injection Product Portfolios and Specifications
13.7.3 Cadila Pharmaceuticals Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cadila Pharmaceuticals Main Business Overview
13.7.5 Cadila Pharmaceuticals Latest Developments
13.8 Bio-Thera Solutions, Ltd.
13.8.1 Bio-Thera Solutions, Ltd. Company Information
13.8.2 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Portfolios and Specifications
13.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio-Thera Solutions, Ltd. Main Business Overview
13.8.5 Bio-Thera Solutions, Ltd. Latest Developments
13.9 Hisun Biopharmaceutical
13.9.1 Hisun Biopharmaceutical Company Information
13.9.2 Hisun Biopharmaceutical Adalimumab Injection Product Portfolios and Specifications
13.9.3 Hisun Biopharmaceutical Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hisun Biopharmaceutical Main Business Overview
13.9.5 Hisun Biopharmaceutical Latest Developments
13.10 Innovent Biologics
13.10.1 Innovent Biologics Company Information
13.10.2 Innovent Biologics Adalimumab Injection Product Portfolios and Specifications
13.10.3 Innovent Biologics Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Innovent Biologics Main Business Overview
13.10.5 Innovent Biologics Latest Developments
13.11 Mylan
13.11.1 Mylan Company Information
13.11.2 Mylan Adalimumab Injection Product Portfolios and Specifications
13.11.3 Mylan Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Mylan Main Business Overview
13.11.5 Mylan Latest Developments
13.12 Zydus Group
13.12.1 Zydus Group Company Information
13.12.2 Zydus Group Adalimumab Injection Product Portfolios and Specifications
13.12.3 Zydus Group Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zydus Group Main Business Overview
13.12.5 Zydus Group Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim Adalimumab Injection Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
13.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
13.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Portfolios and Specifications
13.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Main Business Overview
13.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Latest Developments
13.15 Shanghai Henlius Biotech
13.15.1 Shanghai Henlius Biotech Company Information
13.15.2 Shanghai Henlius Biotech Adalimumab Injection Product Portfolios and Specifications
13.15.3 Shanghai Henlius Biotech Adalimumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Shanghai Henlius Biotech Main Business Overview
13.15.5 Shanghai Henlius Biotech Latest Developments
14 Research Findings and Conclusion
Table 1. Adalimumab Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Adalimumab Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 40mg/0.8ml
Table 4. Major Players of 20mg/0.4ml
Table 5. Global Adalimumab Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Adalimumab Injection Sales Market Share by Type (2018-2023)
Table 7. Global Adalimumab Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Adalimumab Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Adalimumab Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Adalimumab Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Adalimumab Injection Sales Market Share by Application (2018-2023)
Table 12. Global Adalimumab Injection Revenue by Application (2018-2023)
Table 13. Global Adalimumab Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Adalimumab Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Adalimumab Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Adalimumab Injection Sales Market Share by Company (2018-2023)
Table 17. Global Adalimumab Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Adalimumab Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Adalimumab Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Adalimumab Injection Producing Area Distribution and Sales Area
Table 21. Players Adalimumab Injection Products Offered
Table 22. Adalimumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Adalimumab Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Adalimumab Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Adalimumab Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Adalimumab Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Adalimumab Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Adalimumab Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Adalimumab Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Adalimumab Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Adalimumab Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Adalimumab Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Adalimumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Adalimumab Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Adalimumab Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Adalimumab Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Adalimumab Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Adalimumab Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Adalimumab Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Adalimumab Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Adalimumab Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Adalimumab Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Adalimumab Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Adalimumab Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Adalimumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Adalimumab Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Adalimumab Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Adalimumab Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Adalimumab Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Adalimumab Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Adalimumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Adalimumab Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Adalimumab Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Adalimumab Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Adalimumab Injection
Table 58. Key Market Challenges & Risks of Adalimumab Injection
Table 59. Key Industry Trends of Adalimumab Injection
Table 60. Adalimumab Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Adalimumab Injection Distributors List
Table 63. Adalimumab Injection Customer List
Table 64. Global Adalimumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Adalimumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Adalimumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Adalimumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Adalimumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Adalimumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Adalimumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Adalimumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Adalimumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Adalimumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Adalimumab Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Adalimumab Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Adalimumab Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Adalimumab Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AbbVie Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. AbbVie Adalimumab Injection Product Portfolios and Specifications
Table 80. AbbVie Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. AbbVie Main Business
Table 82. AbbVie Latest Developments
Table 83. Amgen Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Amgen Adalimumab Injection Product Portfolios and Specifications
Table 85. Amgen Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Amgen Main Business
Table 87. Amgen Latest Developments
Table 88. Sandoz Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Sandoz Adalimumab Injection Product Portfolios and Specifications
Table 90. Sandoz Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sandoz Main Business
Table 92. Sandoz Latest Developments
Table 93. Fresenius Kabi Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Fresenius Kabi Adalimumab Injection Product Portfolios and Specifications
Table 95. Fresenius Kabi Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Fresenius Kabi Main Business
Table 97. Fresenius Kabi Latest Developments
Table 98. Biogen Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Biogen Adalimumab Injection Product Portfolios and Specifications
Table 100. Biogen Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Biogen Main Business
Table 102. Biogen Latest Developments
Table 103. Celltrion Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Celltrion Adalimumab Injection Product Portfolios and Specifications
Table 105. Celltrion Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Celltrion Main Business
Table 107. Celltrion Latest Developments
Table 108. Cadila Pharmaceuticals Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Cadila Pharmaceuticals Adalimumab Injection Product Portfolios and Specifications
Table 110. Cadila Pharmaceuticals Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Cadila Pharmaceuticals Main Business
Table 112. Cadila Pharmaceuticals Latest Developments
Table 113. Bio-Thera Solutions, Ltd. Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Thera Solutions, Ltd. Adalimumab Injection Product Portfolios and Specifications
Table 115. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Bio-Thera Solutions, Ltd. Main Business
Table 117. Bio-Thera Solutions, Ltd. Latest Developments
Table 118. Hisun Biopharmaceutical Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Hisun Biopharmaceutical Adalimumab Injection Product Portfolios and Specifications
Table 120. Hisun Biopharmaceutical Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Hisun Biopharmaceutical Main Business
Table 122. Hisun Biopharmaceutical Latest Developments
Table 123. Innovent Biologics Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Innovent Biologics Adalimumab Injection Product Portfolios and Specifications
Table 125. Innovent Biologics Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Innovent Biologics Main Business
Table 127. Innovent Biologics Latest Developments
Table 128. Mylan Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Mylan Adalimumab Injection Product Portfolios and Specifications
Table 130. Mylan Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Mylan Main Business
Table 132. Mylan Latest Developments
Table 133. Zydus Group Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Zydus Group Adalimumab Injection Product Portfolios and Specifications
Table 135. Zydus Group Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Zydus Group Main Business
Table 137. Zydus Group Latest Developments
Table 138. Boehringer Ingelheim Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Boehringer Ingelheim Adalimumab Injection Product Portfolios and Specifications
Table 140. Boehringer Ingelheim Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Boehringer Ingelheim Main Business
Table 142. Boehringer Ingelheim Latest Developments
Table 143. Jiangsu Chia Tai-Tianqing Pharmaceutical Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Portfolios and Specifications
Table 145. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Jiangsu Chia Tai-Tianqing Pharmaceutical Main Business
Table 147. Jiangsu Chia Tai-Tianqing Pharmaceutical Latest Developments
Table 148. Shanghai Henlius Biotech Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. Shanghai Henlius Biotech Adalimumab Injection Product Portfolios and Specifications
Table 150. Shanghai Henlius Biotech Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Shanghai Henlius Biotech Main Business
Table 152. Shanghai Henlius Biotech Latest Developments
List of Figures
Figure 1. Picture of Adalimumab Injection
Figure 2. Adalimumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Adalimumab Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Adalimumab Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Adalimumab Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 40mg/0.8ml
Figure 10. Product Picture of 20mg/0.4ml
Figure 11. Global Adalimumab Injection Sales Market Share by Type in 2022
Figure 12. Global Adalimumab Injection Revenue Market Share by Type (2018-2023)
Figure 13. Adalimumab Injection Consumed in Hospitals
Figure 14. Global Adalimumab Injection Market: Hospitals (2018-2023) & (K Units)
Figure 15. Adalimumab Injection Consumed in Clinics
Figure 16. Global Adalimumab Injection Market: Clinics (2018-2023) & (K Units)
Figure 17. Adalimumab Injection Consumed in Others
Figure 18. Global Adalimumab Injection Market: Others (2018-2023) & (K Units)
Figure 19. Global Adalimumab Injection Sales Market Share by Application (2022)
Figure 20. Global Adalimumab Injection Revenue Market Share by Application in 2022
Figure 21. Adalimumab Injection Sales Market by Company in 2022 (K Units)
Figure 22. Global Adalimumab Injection Sales Market Share by Company in 2022
Figure 23. Adalimumab Injection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Adalimumab Injection Revenue Market Share by Company in 2022
Figure 25. Global Adalimumab Injection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Adalimumab Injection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Adalimumab Injection Sales 2018-2023 (K Units)
Figure 28. Americas Adalimumab Injection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Adalimumab Injection Sales 2018-2023 (K Units)
Figure 30. APAC Adalimumab Injection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Adalimumab Injection Sales 2018-2023 (K Units)
Figure 32. Europe Adalimumab Injection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Adalimumab Injection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Adalimumab Injection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Adalimumab Injection Sales Market Share by Country in 2022
Figure 36. Americas Adalimumab Injection Revenue Market Share by Country in 2022
Figure 37. Americas Adalimumab Injection Sales Market Share by Type (2018-2023)
Figure 38. Americas Adalimumab Injection Sales Market Share by Application (2018-2023)
Figure 39. United States Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Adalimumab Injection Sales Market Share by Region in 2022
Figure 44. APAC Adalimumab Injection Revenue Market Share by Regions in 2022
Figure 45. APAC Adalimumab Injection Sales Market Share by Type (2018-2023)
Figure 46. APAC Adalimumab Injection Sales Market Share by Application (2018-2023)
Figure 47. China Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Adalimumab Injection Sales Market Share by Country in 2022
Figure 55. Europe Adalimumab Injection Revenue Market Share by Country in 2022
Figure 56. Europe Adalimumab Injection Sales Market Share by Type (2018-2023)
Figure 57. Europe Adalimumab Injection Sales Market Share by Application (2018-2023)
Figure 58. Germany Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Adalimumab Injection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Adalimumab Injection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Adalimumab Injection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Adalimumab Injection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Adalimumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Adalimumab Injection in 2022
Figure 73. Manufacturing Process Analysis of Adalimumab Injection
Figure 74. Industry Chain Structure of Adalimumab Injection
Figure 75. Channels of Distribution
Figure 76. Global Adalimumab Injection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Adalimumab Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Adalimumab Injection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Adalimumab Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Adalimumab Injection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Adalimumab Injection Revenue Market Share Forecast by Application (2024-2029)
